News ( Year: 2016 )

15 August, 2016

Serving returns: How Ally Bridge expects to build on top of WuXi arbitrage play

China’s Ally Bridge Group hit the investment world’s radar in 2015 with its audacious move to take CRO WuXi PharmaTech Inc. private. If the firm and its partners can engineer the first fruits of that move with the listing of WuXi’s biologics unit in Hong Kong this year, the question is what will be its next moves […]

Read More
18 July, 2016

Ally Bridge Group Congratulates Medtech SA on its Acquisition by Zimmer Biomet

HONG KONG, July 18, 2016 /PRNewswire/ —  Ally Bridge Group (“ABG”), a leading China-global cross-border healthcare-focused investment group, is pleased to announce the sale of its entire stake in Medtech SA (“Medtech” or the “Company”) to Zimmer Biomet Holdings, Inc. (“Zimmer Biomet”), a leading global orthopedics company based in Warsaw, Indiana, USA. Medtech is a […]

Read More
3 May, 2016

Building a Global ‘Bridge’ for Life Science Innovation

By Hui Cai, VP of Corporate Alliances at WuXi AppTec (@HuiCai2) As the globalization of healthcare expands, Frank Yu and his team at Ally Bridge Group continue to differentiate themselves in the market with strategic and fruitful investments, and by boosting growth for life science companies on a global scale. Ally Bridge – a Hong Kong-based […]

Read More
19 April, 2016

Five Questions For Ally Bridge’s Founder Frank Yu

Frank Yu, founder of healthcare-focused investment firm Ally Bridge Group and formerly head of China Investments at Och-Ziff Capital Management, answers five questions in this video interview with Nina Xiang, host of China Money Podcast. Q: What is a key industry trend that is overlooked by most people? A: I would say that everyone tends […]

Read More
4 April, 2016

Ally Bridge Group Expands Personalized Medicine Portfolio, Invests in LinkDoc Technology Limited, China’s Oncology Big Data Company

HONG KONG, April 4, 2016 /PRNewswire/ — Ally Bridge Group (“ABG”), a leading cross-border healthcare-focused investment group, is pleased to announce the completion of its Series B investment into LinkDoc Technology Limited (“LinkDoc” or the “Company”), a leading oncology-focused big data company in China, alongside other leading Chinese and international investors.

Read More
23 March, 2016

Ally Bridge keeps cash flowing in $155M private placement in Tesaro

Hong Kong-based Ally Bridge Group took a hand in a $155 million placement in immuno-oncology biotech Tesaro ($TSRO), joining a funding round led by Kleiner Perkins along with New Enterprise Associates in equal portions. Under the terms, an agreed purchase of 4.4 million shares at $35.19 each set in February has reaped a potential windfall […]

Read More
21 March, 2016

Ally Bridge Group (ABG) Completes Its Investment in TESARO, Inc. (TSRO)

HONG KONG, Mar. 21, 2016 /PRNewswire/ — Ally Bridge Group (“ABG”), a global healthcare-focused investment group, announced that it has completed an equity investment in TESARO, Inc. (NASDAQ: TSRO), an oncology-focused, commercial-stage biopharmaceutical company headquartered in Waltham, Massachusetts, USA. This investment was made as part of a private placement of 4.4 million shares of TSRO […]

Read More